NEOS Investment Management LLC raised its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 10.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 102,582 shares of the conglomerate’s stock after acquiring an additional 10,013 shares during the quarter. NEOS Investment Management LLC’s holdings in Danaher were worth $19,540,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently made changes to their positions in DHR. BlackRock Inc. bought a new position in Danaher in the 2nd quarter worth about $10,492,520,000. State Street Corp increased its position in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares during the period. Capital International Investors boosted its position in shares of Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. Wellington Management Group LLP grew its stake in Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after acquiring an additional 1,542,310 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after acquiring an additional 1,334,221 shares during the period. 79.05% of the stock is owned by institutional investors.
Danaher Stock Performance
Shares of NYSE DHR opened at $207.46 on Friday. The stock’s 50-day moving average is $201.74 and its 200 day moving average is $192.28. The stock has a market cap of $145.84 billion, a price-to-earnings ratio of 36.85, a P/E/G ratio of 2.63 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. HSBC dropped their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Finally, Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $228.91.
Check Out Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
